Trevena Inc. (NASDAQ: TRVN)
$0.24
-0.0027 ( -1.12% ) 261.1K
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Market Data
Open
$0.24
Previous close
$0.24
Volume
261.1K
Market cap
$4.40M
Day range
$0.23 - $0.25
52 week range
$0.19 - $1.12
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| def | Proxies and info statements | 13 | Apr 29, 2024 |
| 8-k | 8K-related | 13 | Apr 22, 2024 |
| pre | Proxies and info statements | 13 | Apr 19, 2024 |
| 8-k | 8K-related | 13 | Apr 09, 2024 |
| 8-k | 8K-related | 47 | Apr 01, 2024 |
| 10-k | Annual reports | 92 | Apr 01, 2024 |
| 8-k | 8K-related | 13 | Mar 21, 2024 |
| 8-k | 8K-related | 14 | Mar 06, 2024 |
| def | Proxies and info statements | 5 | Feb 20, 2024 |
| pre | Proxies and info statements | 4 | Feb 09, 2024 |